Investigational Site Number : 8040003

Ivano-Frankivsk 76018

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed